COVID-19: Serum Institute gets DCGI nod to manufacture Sputnik V vaccine in India
SII has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V at its licensed Hadapsar facility.
Jun 04, 2021, 20:36 PM IST
Serum Institute of India applies to DCGI to manufacture Sputnik V COVID vaccine, seeks indemnity
Amid discussions over possible legal protection to foreign vaccine manufacturers Pfizer and Moderna over their COVID-19 jabs in India, the SII has also sought protection against liabilities.
Jun 03, 2021, 12:32 PM IST
COVID Alert: Delhi left with 3,190 vaccine doses for 18-44 age group
Delhi is left with 3,190 COVID vaccine doses in its balance stock out of which 1,120 doses are of Covaxin and 2,070 of Covishield reserved for the age group 18-44 years.
May 31, 2021, 23:21 PM IST
India to import vaccines to speed up vaccination of entire population
Govt. of India, through NEGVAC, is doing regular interaction with national and international vaccine manufacturers like Pfizer, Moderna etc. to make the COVID-19 vaccines available in-country.
May 28, 2021, 23:31 PM IST
Maharashtra halts COVID vaccination for 18-44 age group, people above 45 to be given priority
The Maharashtra Health Minister also revealed that the Serum Institute of India (SII) has informed the Maharashtra government that it would be able to provide 1.5 crore Covishield vaccines to the state only May 20 onwards.
May 12, 2021, 20:30 PM IST
Threat to Adar Poonawalla: Petition filed in Bombay HC seeks Z+ security for Serum Institute of India CEO, his family
The petitioner said that Poonawalla and his family should be given Z plus security, and his assets should be protected keeping the threats that were being made to Poonawallah as per media reports.
May 06, 2021, 09:04 AM IST
Serum Institute to start phase 3 trials of COVID-19 vaccine Covovax by mid-May
Covovax is the second vaccine candidate after Covishield that SII is manufacturing.
May 04, 2021, 18:09 PM IST
Ahead of virtual summit with PM Narendra Modi, UK PM Boris Johnson announces 1 billion pounds trade deals including £240 investment by Serum Institute of India
Boris Johnson said, "Like every aspect of the UK-India relationship, the economic links between our countries make our people stronger and safer."
May 04, 2021, 15:17 PM IST
Serum Institute working closely with govt, received all kinds of support: Adar Poonawalla
The statement from India's COVID-19 vaccine maker Adar Poonawalla comes at a time when he alleged during an exclusive interview with 'Times' that he ad been receiving threats in India and that he and his family left the country for London after unprecedented "pressure and aggression" over the demand of vaccines.
May 03, 2021, 16:57 PM IST
India to face COVID-19 vaccine shortage till July, says SII chief Adar Poonawalla
Amid the surge in COVID-19 infections in the country, Serum Institute of India (SII) chief Adar Poonawalla revealed that the issue of vaccine shortage in India will last for months.
May 03, 2021, 12:25 PM IST
Powerful Indians making aggressive calls for COVID vaccines: Serum CEO Adar Poonawalla
The Serum Institute chief spoke about receiving aggressive calls from some of the most powerful people in India, demanding supplies of Covishield -- the Oxford/AstraZeneca COVID-19 vaccine that the institute is producing in India.
May 02, 2021, 00:26 AM IST
SII CEO Adar Poonawalla to get 'Y' category security CRPF amid threats from various groups
The Union government's decision came after the Director, Government and Regulatory Affairs at Pune-based Serum Institute of India (SII), Prakash Kumar Singh, had written to Union Home Minister Amit Shah on April 16 requesting security for Adar Poonawalla.
Apr 28, 2021, 20:36 PM IST
COVID-19: PIL in Bombay HC challenges different rates of vaccines by SII, Bharat Biotech
A public interest litigation (PIL) has been filed in the Bombay High Court challenging the different rates for COVID-19 vaccines for the Centre and state governments and requesting direction to the Serum Institute of India (SII) and Bharat Biotech to sell their vaccines at a uniform rate of Rs 150 per dose.
Apr 28, 2021, 12:19 PM IST
President Biden's new policy is an act of vaccine mafia! USA halts import of crucial raw material
Serum Institute of India (SII) Chief Executive Adar Poonawalla has urged US President Joe Biden to lift the export ban on critical raw materials required for the production of COVID-19 vaccines.
Apr 16, 2021, 20:57 PM IST
Serum Institute likely to seek permission for selling Covishield commercially: Report
Serum Institute might seek permission for selling Covishield commercially from the Central Drugs Standard Control Organisation (CDSCO) by the end of April.
Apr 05, 2021, 14:14 PM IST
Fake news alert: South Africa will not return 1 million AstraZeneca COVID-19 vaccines received from Serum Institute of India
South Africa had paused the rollout of AstraZeneca coronavirus vaccine doses this month after preliminary trial data showed they offered minimal protection against mild to moderate illness from the country's dominant COVID-19 variant. The country is now likely to administer Johnson & Johnson COVID-19 vaccines from Wednesday.
Feb 16, 2021, 19:55 PM IST
Pune court rejects trademark-violation plea against Serum Institute over 'Covishield'
On January 4, Cutis-Biotech, a pharmacertical firm, filed a suit in the civil court claiming it was a prior user of the brandname Covishield, and sought to restrain SII from using the name. SII is producing a coronavirus vaccine named Covishield, co-developed by the University of Oxford and British-Swedish company AstraZeneca.
Jan 31, 2021, 08:54 AM IST
Serum Institute of India pegs losses due to fire at over Rs 1000 crore; Maharashtra CM Uddhav Thackeray says probe in blaze on
In the Serum Institute of India (SII) fire that broke out in a five-storey building in the SII's Manjari premises in Pune on January 21 (Thursday), five contractual labourers died. Maharashtra Chief Minister Uddhav Thackeray visited the SII on Friday to take stock of the damages.
Jan 22, 2021, 22:56 PM IST
Serum Institute fire: Know what caused the massive blaze that killed 5 people
Maharashtra Health Minister Rajesh Tope said that the initial fire was caused by some ongoing welding work at the site. The fire broke out at about 2:45 pm at an under-construction building where vaccine production was supposed to start after a month. The fire broke out at 4th and 5th floor of the SEZ3 building. BCG vaccine laboratory was there at 3rd floor of the same building but that is unaffected.
Jan 22, 2021, 07:41 AM IST
In pics: Serum Institute of India fire kills five people; SII announces compensation
Serum Institute of India Pvt Ltd is the world's largest vaccine manufacturer by a number of doses produced and sold globally (more than 1.5 billion doses) which includes Polio vaccine as well as Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines, as per the company's website.
Jan 22, 2021, 00:55 AM IST
